SCHEMBL4383920

SCHEMBL4383920

CCc1c(OCc2ccccc2)cc(OCc2ccccc2)c(-c2cccc(OC)c2)c1CC1O[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.41
ABCB1 P08183 5/20 0.40
HTR1A P08908 2/20 0.40
DRD2 P14416 2/20 0.40
C5AR1 P21730 1/20 0.38
GSK3B P49841 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
ERN1 O75460 1/20 0.37
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LRRK2 Q5S007 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE4A P27815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381051 1.00 MAOB (0.41) MAOBABCB1HTR1ADRD2C5AR1
SCHEMBL4385084 0.90 MAPK14 (0.35) GSK3BCDK5CDK5R1MAPT
SCHEMBL4384038 0.90 MAPK14 (0.35) GSK3BCDK5CDK5R1MAPT
SCHEMBL4381387 0.90 MAPK14 (0.35) GSK3BCDK5CDK5R1MAPT
SCHEMBL4386419 0.89 ESR1 (0.36) GSK3BCDK5CDK5R1ERN1MAPT
SCHEMBL4386156 0.89 ESR1 (0.36) GSK3BCDK5CDK5R1ERN1MAPT
SCHEMBL4382854 0.89 MAPT (0.34) MAOBGSK3BCDK5CDK5R1MAPT
SCHEMBL4392462 0.88 C5AR1 (0.37) HTR1AC5AR1MAPTLRRK2MEN1
SCHEMBL6025486 0.88 C5AR1 (0.37) HTR1AC5AR1MAPTLRRK2MEN1
SCHEMBL4380707 0.88 C5AR1 (0.37) HTR1AC5AR1MAPTLRRK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P MAOB 3920/4885ABCB1 204/4885HTR1A 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.